Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives
Genes · 2025
DOI: 10.3390/genes16040399 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von Yilong Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China. Hauptthemen laut MEDLINE: Transcriptome, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Natural Science Foundation of Shanghai, the construction project of Shanghai Key Laboratory of Molecular Imaging.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of fatty liver disease, presents a significant global health challenge. Despite extensive research, fully elucidating its complex pathogenesis and developing accurate non-invasive diagnostic tools remain key goals. Multi-omics approaches, integrating data from transcriptomics, proteomics, metabolomics, and lipidomics, offer a powerful strategy to achieve these aims. This review summarizes key findings from multi-omics studies in MASH, highlighting their contributions to our understanding of disease mechanisms and the development of improved diagnostic models. Transcriptomic studies have revealed widespread gene dysregulation affecting lipid metabolism, inflammation, and fibrosis, while proteomics has identified altered protein expression patterns and potential biomarkers. Metabolomic and lipidomic analyses have further uncovered significant changes in various metabolites and lipid species, including ceramides, sphingomyelins, phospholipids, and bile acids, underscoring the central role of lipid dysregulation in MASH. These multi-omics findings have been leveraged to develop novel diagnostic models, some incorporating machine learning algorithms, with improved accuracy compared to traditional methods. Further research is needed to validate these findings, explore the complex interplay between different omics layers, and translate these discoveries into clinically useful tools for improved MASH diagnosis and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
- Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
ORCID-Profile: Yilong Chen, Jiamei Le
Förderung
- National Natural Science Foundation of China
- the Natural Science Foundation of Shanghai
- the construction project of Shanghai Key Laboratory of Molecular Imaging
- the Climbing Program of Shanghai University of Medicine and Health Sciences
- Natural Science Foundation of Shanghai
- Climbing Program of Shanghai University of Medicine and Health Sciences
Zitieren
APA
Chen, Y., Bian, S., & Le, J. (2025). Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives. Genes. https://doi.org/10.3390/genes16040399
Vancouver
Chen Y, Bian S, Le J. Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives. Genes. 2025. doi:10.3390/genes16040399
BibTeX
@article{Chen2025,
author = {Chen, Yilong and Bian, Shuixiu and Le, Jiamei},
title = {Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16040399}
}
EUVIMED